Market Tracker

04/24 6:02pm ET

Amgen Inc (NASDAQ:AMGN)

167.91
Delayed Data
As of Apr 24
 -1.26 / -0.74%
Today’s Change
108.20
Today|||52-Week Range
173.60
+5.41%
Year-to-Date

Today’s Trading

Previous close169.17
Today’s open168.15
Day’s range166.06 - 169.25
Volume2,548,315
Average volume (3 months)3,456,715
Market cap$127.3B
Dividend yield1.88%
Data as of 4:14pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+9.64%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)+7.30%
P/E ratio25.1
Price/Sales6.03
Price/Book4.95

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-1.51-1.44%
BIIBBiogen-28.57-6.64%
BAXBaxter International...-0.37-0.52%
JUNOJuno Therapeutics In...-1.06-1.84%
Data as of 4:00pm ET, 04/24/2015

Financials

Last reporting dateApril 21, 2015
EPS forecast (this quarter)$2.48
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhu Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts